I. Bhan

发表

Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage.

G. Lahav, Eric Batchelor, Caroline S. Mock, 2008, Molecular cell.

Physicians’ Perspectives on Palliative Care for Patients With End‐Stage Liver Disease: A National Survey Study

J. Temel, R. Chung, I. Bhan, 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Spontaneous Immune-Mediated Regression of Hepatocellular Carcinoma With High Tumor Mutational Burden

I. Bhan, D. Ting, V. Deshpande, 2021, JCO precision oncology.

Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease.

J. Temel, R. Chung, I. Bhan, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

PLSec: A novel, liquid biomarker for HCC risk.

A. Zhu, I. Bhan, J. Franses, 2021, Med.

Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management

I. Bhan, P. Bloom, N. Hashemi, 2020, Digestive Diseases and Sciences.

Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study.

C. Newton-Cheh, R. Chung, I. Bhan, 2019, The lancet. Gastroenterology & hepatology.

Acute Lower Gastrointestinal Bleeding.

I. Bhan, J. Richter, Dmitriy Kedrin, 2012, The New England journal of medicine.

Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target

G. Daley, D. Haber, S. Maheswaran, 2020, Nature Communications.

Somatic Mutations in Liver Disease: Adaptation Without Carcinogenesis?

I. Bhan, D. Ting, 2020, Hepatology.

Liquid Biopsy in Hepatocellular Carcinoma

D. Haber, R. Chung, I. Bhan, 2019, Molecular and Translational Medicine.

Immediate administration of antiviral therapy after transplantation of hepatitis C‐infected livers into uninfected recipients: Implications for therapeutic planning

A. Cuenca, R. Chung, I. Bhan, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies

Jeffrey W. Clark, A. Kambadakone, A. Zhu, 2023, The oncologist.

Case 4-2023: A 56-Year-Old Man with Abnormal Results on Liver Testing.

William R. Bradley, I. Bhan, Esperance A K Schaefer, 2023, The New England journal of medicine.

Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target

G. Daley, D. Haber, S. Maheswaran, 2020, Nature Communications.

An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma

D. Weitz, K. Isselbacher, D. Haber, 2017, Proceedings of the National Academy of Sciences.

Hepatic vascular remodelling in a patient with dyskeratosis congenita

Suneet Agarwal, I. Bhan, J. Markmann, 2021, Histopathology.

Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies From Patients With Liver Disease.

D. Haber, M. Toner, S. Maheswaran, 2018, Gastroenterology.